Michael Crosnick’s Post

View profile for Michael Crosnick, graphic

Healthcare Operations Strategist | Managed Care Specialist | Process Management | Data Analysis & Reporting

The article from The Wall Street Journal discusses how the Apple Watch is increasingly becoming a favored medical device among doctors, even in cases where it hasn't received official approval from regulatory bodies like the FDA. Here's a summary of the key points: Practical application: The author's mother, who suffers from atrial fibrillation (a type of cardiac arrhythmia), was advised by her doctor to get an Apple Watch SE. She now considers it an essential tool in managing her health. Data transmission: The Apple Watch allows patients to easily send health data to their healthcare providers, facilitating ongoing adjustments to treatment plans and lifestyle recommendations. Widespread adoption: Many physicians are incorporating the Apple Watch into their diagnostic and treatment strategies, recognizing its potential to provide valuable health insights. Regulatory status: Despite lacking official approval for some medical applications, doctors are finding ways to utilize the Apple Watch's capabilities in patient care. Patient empowerment: The device enables patients to take a more active role in monitoring their health, potentially leading to earlier detection of issues and more personalized care. While the article doesn't provide specific statistics on adoption rates or comparative effectiveness with other medical devices, it highlights the growing trend of wearable technology integration in healthcare. The Apple Watch's ability to collect and transmit real-time health data is positioning it as a valuable tool for both patients and healthcare providers in managing various health conditions. https://lnkd.in/erq9KfqP #healthcare #healthcareinnovation #healthcareit #digitalhealth #mobilehealth #wearabletech #rpm #AppleWatch

 Apple Watch Is Becoming Doctors’ Favorite Medical Device

 Apple Watch Is Becoming Doctors’ Favorite Medical Device

wsj.com

To view or add a comment, sign in

Explore topics